Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer (SUBMIT)

This study has been terminated.
(due to low accrual rate)
Sponsor:
Collaborators:
Borstkanker Onderzoek Groep
Comprehensive Cancer Centre The Netherlands
Information provided by (Responsible Party):
M.F. Ernst, dr, Jeroen Bosch Ziekenhuis
ClinicalTrials.gov Identifier:
NCT01392586
First received: July 5, 2011
Last updated: February 2, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):